Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

ArisGlobal Announces Significant Customer Growth and Unprecedented Product Innovations in 2024

This image opens in the lightbox

News provided by

ArisGlobal

29 Jan, 2025, 15:30 GMT

Share this article

Share toX

Share this article

Share toX

11 net new LifeSphere customers, 57 customer go-lives, and expanded adoption of NavaX

BOSTON, Jan. 29, 2025 /PRNewswire/ -- ArisGlobal, an innovative technology company at the forefront of life sciences and creator of LifeSphere®, today announced 2024 as a landmark year, marked by notable customer growth, a record-breaking number of global implementations, and creation and deployment of next-generation technologies as part of LifeSphere NavaX.

Customer Acquisition and Expansion
LifeSphere Safety and Regulatory platforms leverage cutting-edge technology to enhance workflows, boost efficiency, and lower costs, with more organizations embracing these solutions. ArisGlobal reports significant customer growth throughout 2024, including:

  • 11 net new, top tier pharma LifeSphere customers, added January through December;
  • 91 customers expanded their business, demonstrating continued success in leveraging LifeSphere solutions;
  • Strong customer growth in the Asia Pacific region; 40% YoY increase in new customers in APAC.

Also in 2024, ArisGlobal announced its 'Most Valued Customer' program to continue forging deeper customer experiences with its most strategic customers. Members gain exclusive benefits, including premium support, early access to new features, input on product innovation, and invitations to ArisGlobal industry events.

Steve Nuckols, Chief Customer Officer, stated, "Our 2024 growth reflects the tangible ROI our solutions deliver for customers worldwide. By actively listening to our customers and continuously enhancing our offerings, we're driving satisfaction and innovation. Additionally, our success in APAC showcases our commitment to expanding in key markets and meeting the unique needs of our clients globally."

Global Implementations and Consulting Success
ArisGlobal experts excel in planning, implementing, and deploying cloud-based solutions for users across the globe, achieving a notable 23% YoY increase in total LifeSphere go-lives.

With customers having confidence in LifeSphere, ArisGlobal saw impressive go-live momentum, including:

  • 57 total go-lives across Safety and Regulatory;
  • 14 total go-lives in APAC, representing a 40% YoY increase;
  • Implementations for three of the Top 10 global pharmaceutical companies.

Raj Hattarki, Chief Operating Officer, remarked, "Our ability to provide end-to-end support before, during, and after LifeSphere implementations is a cornerstone of our success. Backed by deep life sciences expertise, we help organizations scale and meet complex challenges. This approach ensures our clients' success and underscores the trust they place in us to deliver results."

Product Innovation
ArisGlobal invested in product innovation at an unprecedented pace throughout 2024. The company launched, built, and deployed LifeSphere NavaX, a next generation cognitive computing engine to expedite R&D IT digitization by leveraging advanced technologies like Large Language Models (LLM) and Generative AI (GenAI).

Since the launch, the company has introduced advanced products and features across LifeSphere Safety and Regulatory offerings bringing customers over 50% efficiency gains with 90% accuracy. These solutions are system-agnostic, modular in nature, and can be implemented rapidly, within three to six months, including:

  • Advanced Intake – The industry's most advanced solution for automating the collection of safety data; revolutionizing the traditional approach to adverse event case intake with the application of Dynamic Data Extraction and Narrative Generation technologies.
  • Advanced Signals - Achieve unmatched speed, precision, and accuracy in signal detection, while gaining insights needed to act with confidence and proactively prevent safety issues.
  • Literature Intelligence - Leverage Dynamic Data Extraction for literature intake and assessment, purpose-built to automate workflows for increased efficiency and data accuracy.
  • Health Authority Interactions – Provides Regulatory teams with speed and accuracy to avoid late Health Authority responses; enhances clarity for better decision making, while improving quality, compliance, and insights via the application of Narrative Generation technology.
  • Regulatory Intelligence – Improves efficiency in capturing, processing, and distribution of regulatory intelligence reducing non-compliance risks and improving decision-making through automation; leverages Dynamic Data Extraction.

Today, four global pharmaceutical companies have adopted LifeSphere NavaX, affirming its value in transforming Safety, Regulatory, and Medical Affairs workflows. This achievement highlights NavaX's role in advancing pharmacovigilance processes.

Additionally, in 2024, ArisGlobal launched a first-of-its-kind GenAI Council and CXO Connect forums, in February and August 2024 respectively. These initiatives provide a collaborative platform for pharma executives and industry leaders to explore and shape the future of R&D; they foster meaningful discussion on the practical applications of GenAI in life sciences.

Ann-Marie Orange, CIO and Global Head of R&D, shared, "Our focus is on delivering technology that directly addresses the challenges our customers face. With NavaX, we're deploying practical, scalable innovations that matter most to our clients. Our commitment to strategic technology application ensures we're enabling real-world results in a rapidly evolving industry."

Looking Ahead
ArisGlobal's 2024 accomplishments set the stage for continued progress and innovation in 2025. The company remains steadfast in its mission to empower life sciences organizations with solutions that drive efficiency, regulatory compliance, and better patient outcomes.

Aman Wasan, CEO of ArisGlobal, concluded, "The life sciences industry is navigating increasing R&D costs, heightened regulatory demands, and outdated workflows. ArisGlobal is committed to solving these pressing challenges with smart, impactful use of technology to unlock and deliver benefits via LifeSphere NavaX. As we look ahead, we'll continue to drive the advancements that position our customers for success and transform the future of life sciences."

About ArisGlobal
ArisGlobal, an innovative life sciences technology company and creator of LifeSphere®, is transforming the way today's most successful life sciences companies develop breakthroughs and bring new products to market. Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan, and China. For more updates, follow ArisGlobal on LinkedIn or visit arisglobal.com.

Logo - https://mma.prnewswire.com/media/1510670/ArisGlobal_Logo.jpg

Modal title

Also from this source

Global Pharma Organization Implements Advanced Signals as Part of LifeSphere Safety Platform

Global Pharma Organization Implements Advanced Signals as Part of LifeSphere Safety Platform

ArisGlobal, an innovative technology company at the forefront of life sciences and creator of LifeSphere®, today announced that another top-tier...

Launched at Breakthrough 2025, ArisGlobal announces LifeSphere Unify, NavaX Insights, and Advanced Compliance Docs

Launched at Breakthrough 2025, ArisGlobal announces LifeSphere Unify, NavaX Insights, and Advanced Compliance Docs

ArisGlobal, a leading life sciences technology company and creator of LifeSphere®, today announced three new cutting-edge product offerings that will ...

More Releases From This Source

Explore

Cloud Computing/Internet of Things

Cloud Computing/Internet of Things

Internet Technology

Internet Technology

Telecommunications Industry

Telecommunications Industry

Computer & Electronics

Computer & Electronics

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.